Terms: = Leukemia AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Clinical Outcome
3 results:
1. High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.
Zhang H; Zhang N; Wang R; Shao T; Feng Y; Yao Y; Wu Q; Zhu S; Cao J; Zhang H; Li Z; Liu X; Niu M; Xu K
J Transl Med; 2019 Apr; 17(1):106. PubMed ID: 30935386
[TBL] [Abstract] [Full Text] [Related]
2. Age-related clinical and biological features of pten abnormalities in T-cell acute lymphoblastic leukaemia.
Tesio M; Trinquand A; Ballerini P; Hypolite G; Lhermitte L; Petit A; Ifrah N; Baruchel A; Dombret H; Macintyre E; Asnafi V
Leukemia; 2017 Dec; 31(12):2594-2600. PubMed ID: 28539671
[TBL] [Abstract] [Full Text] [Related]
3. Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome.
Cheong JW; Eom JI; Maeng HY; Lee ST; Hahn JS; Ko YW; Min YH
Br J Haematol; 2003 Aug; 122(3):454-6. PubMed ID: 12877673
[TBL] [Abstract] [Full Text] [Related]
